Side-by-side comparison of AI visibility scores, market position, and capabilities
Western US supermarket chain with 900 stores under Albertsons Companies; Signature Select private label and Just for U loyalty program competing with Kroger after blocked merger.
Safeway is a major American supermarket chain operating approximately 900 stores primarily in the Western United States, Mid-Atlantic, and Alaska — known for its Signature Select private label products, Club Card loyalty program, and full-service deli, bakery, and pharmacy departments. Safeway is owned by Albertsons Companies (which acquired Safeway in 2015 for approximately $9.2 billion), making Safeway one of the Albertsons family of store banners alongside Vons, Jewel-Osco, Shaw's, Randalls, and others.\n\nSafeway's stores follow a traditional full-service supermarket model with departments including produce, meat, seafood, deli, bakery, floral, and pharmacy. The Signature Select and O Organics private label lines provide margin-accretive alternatives across grocery, meat, and dairy categories. The Just for U loyalty program (now integrated into the Albertsons apps) provides personalized digital coupons and rewards for Club Card members.\n\nIn 2025, Safeway operates within the broader Albertsons Companies portfolio (NYSE: ACI) following the failed merger with Kroger — the FTC successfully blocked the $25 billion Kroger-Albertsons merger in February 2024 after multiple years of regulatory review. Post-merger attempt, Albertsons Companies is refocusing on organic growth and operational efficiency for its banner portfolio. Safeway competes with Kroger, Trader Joe's, Costco, and regional grocers for Western US supermarket share. The 2025 strategy focuses on digital grocery pickup and delivery expansion, private label penetration, and store remodeling to compete with fresh-focused competitors like Whole Foods.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.